PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of BioMolecular Sciences, University of Mississippi, Oxford, Mississippi, 38677, USA.\', \'Department of Microbiology and Immunology, University of Mississippi Medical Center, Jackson, Mississippi, 39216, USA.\', \'Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, 39216, USA.\', \'Department of Neurology, University of Mississippi Medical Center, Jackson, Mississippi, 39216, USA.\', \'National Center for Natural Products Research, University of Mississippi, Oxford, Mississippi, 38677, USA.\', \'Department of Pharmaceutics and Drug Delivery, University of Mississippi, Oxford, Mississippi, 38677, USA.\', \'Department of Pharmaceutical Sciences, Mercer University, Atlanta, Georgia, 30341, USA.\', \'Department of BioMolecular Sciences, University of Mississippi, Oxford, Mississippi, 38677, USA. jsharp@olemiss.edu.\', \'Department of Chemistry and Biochemistry, University of Mississippi, Oxford, Mississippi, 38677, USA. jsharp@olemiss.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s11095-022-03191-4
?:doi
?:hasPublicationType
?:journal
  • Pharmaceutical research
is ?:pmid of
?:pmid
?:pmid
  • 35237922
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.077
?:rankingScore_hIndex
  • 182
is ?:relation_isRelatedTo_publication of
?:title
  • Safety and Pharmacokinetics of Intranasally Administered Heparin.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all